Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Oct 18, 2020 8:32pm

86 Views

Post# 31736918

RE:RE:Fade for Weekend; Close $0.29; 146k

Last year on Oct 16th we were given a clinical update with fasting C-peptide, personally I felt that was the most significant NR to date but ultimately it's the institutions /pharma that need a certain amount of data and until we reach that threshold updates for the retail crowd will have little effect on sp however we are due.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal